Company Dossier · Health Care
Medtronic
- S&P 500
- S&P 100
- Russell 1000
What Medtronic is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.
Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →
The latest read
Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.
- Revenue over the four quarters to July 31, 2026: $37.5 billion, up 9.8% from a year earlier.SEC EDGAR filings (XBRL)
- Free cash flow (operating cash flow minus capital expenditure) over the four quarters to July 31, 2026: $6.13 billion, up 16% from a year earlier.SEC EDGAR filings (XBRL)
- Capital expenditure over the four quarters to July 31, 2026: $1.90 billion, up 3.3% from a year earlier.SEC EDGAR filings (XBRL)
- Share buybacks in the fiscal year to April 24, 2026: $1.04 billion.SEC EDGAR filings (10-K)
- Long-term debt issued in the fiscal year to April 24, 2026: $1.75 billion.SEC EDGAR filings (10-K)
- Latest earnings call or results release (September 1, 2026): sentiment 0.70 on a −1 to +1 scale (confident, opportunity-framed), confidence 0.90 of 1.Palanor Discourse
- Guidance in the last 90 days: 2 outlook figures raised, 0 lowered, 0 held.Guidance Ledger (8-K results releases)
- Latest annual report (filed June 18, 2026): 2 risk factors added, 2 removed.Risk Factor Changes (10-K Item 1A)
- Insiders were net sellers in Q3 2026: $0.4 million on the open market.SEC Form 4
- 2,142 institutional managers reported a position at June 30, 2026 (−102 on the quarter before).SEC Form 13F
- H-1B filings certified in Q2 2026: 192 (170 a year earlier).U.S. Department of Labor (OFLC)
Company Posture
How Company Posture is measured →What Medtronic is doing, on three axes, from its filings and its own words, as of 2026-10-22. A description, not a rating: Company Posture never says whether to buy.
Retrenching · Hedging
Expanding ↔ Retrenching
Retrenching
- Capital spending36th pct
- Debt raised33rd pct
- Buybacks vs capex67th pct
- Hiring filings13th pct
- Deals and private raises49th pct
- Patent publications41st pct
Confident ↔ Hedging
Hedging
- Call sentiment66th pct
- Call confidence90th pct
- Guidance changes65th pct
- Risk factors added29th pct
- Insider open-market trades37th pct
- + Call confidence
- + Call sentiment
- + Guidance changes
Pressure
Components only: Not yet shown as a score: in the back-test it did not add to a naive reader's forecast of impairment, debt acceleration or bankruptcy filings (8-K 2.06, 2.04, 1.03) (not enough events (17 in half 1; needs 20)).
- Fails-to-deliver68th pct
- Stress filings48th pct
Credit
How these are built →Medtronic's borrowing from its SEC filings: the bonds it priced and the debt on its latest balance sheet. A description, not a rating.
Debt on the balance sheet
$28.2B
- Due within a year $2.5B
- Longer term $25.6B
- Default point $15.3B (short + ½ long)
Finance leases included · Jul 31, 2026 filing
Bonds priced, last 12 months
None
U.S. dollar tranches with a term sheet on EDGAR. Deals sold under Rule 144A file none and are not counted.
Charts
Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.
Cash flow
Capital returned and raised
What the company says
Hiring and ownership
In the news
Headlines that name Medtronic, with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.
- NeutralMedtronic Has Been Boring Investors for Years. That Could Be Changing
insidermonkey.com · via Marketaux · Oct 3, 2026
Filings and records
The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.
- Oct 20, 2026LobbyingLobbying report (MINIMED GROUP, INC.)third_quarter 2026 · $0.2 million
- Oct 20, 2026LobbyingLobbying report (MEDTRONIC, INC.)third_quarter 2026 · $1.6 million
- Oct 20, 2026LobbyingLobbying report (LIBERTY PARTNERS GROUP, LLC)third_quarter 2026
- Oct 20, 2026LobbyingLobbying report (W STRATEGIES, LLC)third_quarter 2026 · $0.0 million
- Oct 20, 2026LobbyingLobbying report (LIBERTY PARTNERS GROUP, LLC)third_quarter 2026
- Oct 20, 2026LobbyingLobbying report (MEHLMAN CONSULTING, INC.)third_quarter 2026 · $0.1 million
- Oct 20, 2026LobbyingLobbying report (MEHLMAN CONSULTING, INC.)third_quarter 2026 · $0.1 million
- Oct 20, 2026Patent
- Oct 20, 2026Patent
- Oct 20, 2026Patent
- Oct 20, 2026Patent
- Oct 20, 2026Patent
- Oct 19, 20268-KDirector or officer changeItem 5.02
- Oct 19, 20268-KShareholder vote resultsItem 5.07
- Jul 21, 2026LobbyingLobbying report (MEDTRONIC, INC.)second_quarter 2026 · $1.2 million
- Jun 18, 202610-KAnnual report (10-K)2 risk factors added, 2 removed
- May 18, 20268-KDirector or officer changeItem 5.02
- Nov 3, 20258-KDirector or officer changeItem 5.02
- Oct 21, 20258-KShareholder vote resultsItem 5.07
- Sep 29, 20258-KMaterial agreement signedItem 1.01
- Aug 19, 20258-KDirector or officer changeItem 5.02
- Jun 23, 20258-KDirector or officer changeItem 5.02
- Jun 20, 202510-KAnnual report (10-K)0 risk factors added, 0 removed
- May 21, 20258-KDirector or officer changeItem 5.02
- Mar 17, 20258-KDirector or officer changeItem 5.02
- Jan 21, 20258-KDirector or officer changeItem 5.02
- Oct 21, 20248-KShareholder vote resultsItem 5.07
- Jun 20, 202410-KAnnual report (10-K)1 risk factors added, 0 removed
Peers
Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.
| Company | Revenue | Free cash flow | Through |
|---|---|---|---|
| Stryker Corporation SYK | $25.8B | $4.7B | Jun 30, 2026 |
| Becton Dickinson BDX | $22.5B | $2.7B | Jun 30, 2026 |
| Boston Scientific BSX | $21.0B | $3.6B | Jun 30, 2026 |
| GE HealthCare GEHC | $21.0B | — | Mar 31, 2026 |
| Baxter International BAX | $11.5B | — | Jun 30, 2026 |
| Intuitive Surgical ISRG | $11.0B | $3.2B | Jun 30, 2026 |
| Zimmer Biomet ZBH | $8.5B | $1.5B | Jun 30, 2026 |
| Edwards Lifesciences EW | $6.5B | $1.4B | Jun 30, 2026 |